176 related articles for article (PubMed ID: 25027005)
1. [Prevention of prostate cancer. Long-term results of the Prostate Cancer Prevention Trial (PCPT)].
Michel MS; Nitschmann S; von Hardenberg J
Internist (Berl); 2014 Aug; 55(8):981-2. PubMed ID: 25027005
[No Abstract] [Full Text] [Related]
2. Re: long-term survival of participants in the Prostate Cancer Prevention Trial.
Kaplan SA
J Urol; 2014 Feb; 191(2):359. PubMed ID: 24411852
[No Abstract] [Full Text] [Related]
3. Re: long-term survival of participants in the Prostate Cancer Prevention Trial.
Seftel AD
J Urol; 2014 Feb; 191(2):359. PubMed ID: 24411851
[No Abstract] [Full Text] [Related]
4. Re: long-term survival of participants in the Prostate Cancer Prevention Trial.
Taneja SS
J Urol; 2014 Feb; 191(2):358. PubMed ID: 24411850
[No Abstract] [Full Text] [Related]
5. A role for finasteride in the prevention of prostate cancer?
LeFevre M
N Engl J Med; 2013 Aug; 369(7):670-1. PubMed ID: 23944306
[No Abstract] [Full Text] [Related]
6. Survival in the prostate cancer prevention trial.
Revannasiddaiah S; Susheela SP
N Engl J Med; 2013 Nov; 369(20):1967. PubMed ID: 24224634
[No Abstract] [Full Text] [Related]
7. Survival in the prostate cancer prevention trial.
Walsh PC
N Engl J Med; 2013 Nov; 369(20):1967. PubMed ID: 24224633
[No Abstract] [Full Text] [Related]
8. Survival in the prostate cancer prevention trial.
Tangen CM; Goodman PJ; Thompson IM
N Engl J Med; 2013 Nov; 369(20):1968. PubMed ID: 24224632
[No Abstract] [Full Text] [Related]
9. Prostate cancer prevention with 5 alpha-reductase inhibitors.
Parekh DJ
Recent Results Cancer Res; 2011; 188():109-14. PubMed ID: 21253793
[No Abstract] [Full Text] [Related]
10. Few physicians prescribe 5-alpha reductase inhibitors for prostate cancer prevention.
Barton MK
CA Cancer J Clin; 2011; 61(1):1-2. PubMed ID: 21199914
[No Abstract] [Full Text] [Related]
11. Long-term survival of participants in the prostate cancer prevention trial.
Thompson IM; Goodman PJ; Tangen CM; Parnes HL; Minasian LM; Godley PA; Lucia MS; Ford LG
N Engl J Med; 2013 Aug; 369(7):603-10. PubMed ID: 23944298
[TBL] [Abstract][Full Text] [Related]
12. Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.
Unger JM; Till C; Thompson IM; Tangen CM; Goodman PJ; Wright JD; Barlow WE; Ramsey SD; Minasian LM; Hershman DL
J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27565902
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer: mortality unaffected by finasteride treatment.
Payton S
Nat Rev Urol; 2013 Oct; 10(10):551. PubMed ID: 24018566
[No Abstract] [Full Text] [Related]
14. Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial.
Murtola TJ; Gurel B; Umbehr M; Lucia MS; Thompson IM; Goodman PJ; Kristal AR; Parnes HL; Lippman SM; Sutcliffe S; Peskoe SB; Barber JR; Drake CG; Nelson WG; De Marzo AM; Platz EA
Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):463-9. PubMed ID: 26715424
[TBL] [Abstract][Full Text] [Related]
15. Circadian genes and risk of prostate cancer in the prostate cancer prevention trial.
Chu LW; Till C; Yang B; Tangen CM; Goodman PJ; Yu K; Zhu Y; Han S; Hoque AM; Ambrosone C; Thompson I; Leach R; Hsing AW
Mol Carcinog; 2018 Mar; 57(3):462-466. PubMed ID: 29318656
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of prostate cancer.
Vemana G; Hamilton RJ; Andriole GL; Freedland SJ
Annu Rev Med; 2014; 65():111-23. PubMed ID: 24188663
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Effects of Finasteride on Prostate Cancer Mortality.
Goodman PJ; Tangen CM; Darke AK; Lucia MS; Ford LG; Minasian LM; Parnes HL; LeBlanc ML; Thompson IM
N Engl J Med; 2019 Jan; 380(4):393-394. PubMed ID: 30673548
[No Abstract] [Full Text] [Related]
18. [The Prostate Cancer Prevention Trial (PCPT). Relevance for clinical practice].
Schmitz-Dräger BJ; Fischer C; Bismarck E; Dörsam HJ; Lümmen G
Urologe A; 2007 Oct; 46(10):1364, 1366-8, 1370. PubMed ID: 17874228
[TBL] [Abstract][Full Text] [Related]
19. The risks and benefits of 5α-reductase inhibitors for prostate-cancer prevention.
Theoret MR; Ning YM; Zhang JJ; Justice R; Keegan P; Pazdur R
N Engl J Med; 2011 Jul; 365(2):97-9. PubMed ID: 21675880
[No Abstract] [Full Text] [Related]
20. Health-related quality-of-life findings for the prostate cancer prevention trial.
Moinpour CM; Darke AK; Donaldson GW; Cespedes D; Johnson CR; Ganz PA; Patrick DL; Ware JE; Shumaker SA; Meyskens FL; Thompson IM
J Natl Cancer Inst; 2012 Sep; 104(18):1373-85. PubMed ID: 22972968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
